Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sally A Roberts

Showing results (61-70 of 69) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 69 results.
Antimicrobial Agents and Chemotherapy|January 22, 2013
Vancomycin AUC/MIC ratio and 30-day mortality in patients with Staphylococcus aureus bacteremiaNatasha E Holmes, John D Turnidge, Wendy J Munckhof, et al.
The Journal of Infectious Diseases|July 12, 2011
Antibiotic choice may not explain poorer outcomes in patients with Staphylococcus aureus bacteremia and high vancomycin minimum inhibitory concentrationsNatasha E Holmes, John D Turnidge, Wendy J Munckhof, et al.
Journal of Clinical Microbiology|April 7, 2017
Target-Specific Assay for Rapid and Quantitative Detection of Mycobacterium chimaera DNAEnrique Zozaya-Valdés, Jessica L Porter, John Coventry, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 7, 2004
Treatment outcomes for serious infections caused by methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibilityBenjamin P Howden, Peter B Ward, Patrick G P Charles, et al.
Journal of Clinical Microbiology|July 18, 2014
Genetic and molecular predictors of high vancomycin MIC in Staphylococcus aureus bacteremia isolatesNatasha E Holmes, John D Turnidge, Wendy J Munckhof, et al.
Clinical & Translational Immunology|March 22, 2021
Comprehensive analysis of SARS-CoV-2 antibody dynamics in New ZealandAlana L Whitcombe, Reuben McGregor, Alyson Craigie, et al.
Antimicrobial Resistance and Infection Control|March 29, 2018
Vancomycin-resistant <i>Enterococcus faecium</i> sequence type 796 - rapid international dissemination of a new epidemic cloneAndrew A Mahony, Andrew H Buultjens, Susan A Ballard, et al.
Peerj|September 21, 2020
Collaborative networks enable the rapid establishment of serological assays for SARS-CoV-2 during nationwide lockdown in New ZealandReuben McGregor, Alana L Whitcombe, Campbell R Sheen, et al.
The Lancet. Infectious Diseases|June 15, 2019
The burden of Legionnaires' disease in New Zealand (LegiNZ): a national surveillance studyPatricia C Priest, Sandy Slow, Stephen T Chambers, et al.
Pageof 7

Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
Antimicrobial Agents and Chemotherapy|January 22, 2013
Vancomycin AUC/MIC ratio and 30-day mortality in patients with Staphylococcus aureus bacteremiaNatasha E Holmes, John D Turnidge, Wendy J Munckhof, et al.
The Journal of Infectious Diseases|July 12, 2011
Antibiotic choice may not explain poorer outcomes in patients with Staphylococcus aureus bacteremia and high vancomycin minimum inhibitory concentrationsNatasha E Holmes, John D Turnidge, Wendy J Munckhof, et al.
Journal of Clinical Microbiology|April 7, 2017
Target-Specific Assay for Rapid and Quantitative Detection of Mycobacterium chimaera DNAEnrique Zozaya-Valdés, Jessica L Porter, John Coventry, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 7, 2004
Treatment outcomes for serious infections caused by methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibilityBenjamin P Howden, Peter B Ward, Patrick G P Charles, et al.
Journal of Clinical Microbiology|July 18, 2014
Genetic and molecular predictors of high vancomycin MIC in Staphylococcus aureus bacteremia isolatesNatasha E Holmes, John D Turnidge, Wendy J Munckhof, et al.
Clinical & Translational Immunology|March 22, 2021
Comprehensive analysis of SARS-CoV-2 antibody dynamics in New ZealandAlana L Whitcombe, Reuben McGregor, Alyson Craigie, et al.
Antimicrobial Resistance and Infection Control|March 29, 2018
Vancomycin-resistant <i>Enterococcus faecium</i> sequence type 796 - rapid international dissemination of a new epidemic cloneAndrew A Mahony, Andrew H Buultjens, Susan A Ballard, et al.
Peerj|September 21, 2020
Collaborative networks enable the rapid establishment of serological assays for SARS-CoV-2 during nationwide lockdown in New ZealandReuben McGregor, Alana L Whitcombe, Campbell R Sheen, et al.
The Lancet. Infectious Diseases|June 15, 2019
The burden of Legionnaires' disease in New Zealand (LegiNZ): a national surveillance studyPatricia C Priest, Sandy Slow, Stephen T Chambers, et al.
Pageof 7